Joshua Brumm
President and Chief Executive Officer at Dyne Therapeutics
Direct reports
Joanne Bryce
Director, FinanceSusanna High
Chief Operating OfficerOxana Beskrovnaya
SVP, Head of ResearchChris Mix
SVP, Clinical DevelopmentJonathan McNeill
VP, Business DevelopmentDebra Feldman
VP, Head of RegulatoryGene Kim
VP, FinanceRomesh Subramanian
Chief Scientific OfficerJohn Najim
VP, Chemistry, Manufacturing and ControlsMo Qatanani
VP, DiscoveryMolly White
VP, Medical Communications and AdvocacyJohn Davis
VP, Head of Preclinical DevelopmentRick Scalzo
VP, Accounting and AdministrationAmy Reilly
VP, Corporate Communications and Investor RelationsDaniel Wilson
VP, Head of Intellectual Property
